PUBLICATIONS
- A Semiparametric Approach to Hazard Estimation with Randomly Censored Observations: https://doi.org/10.2307/
2965405 - Design and Analysis for Demonstrating Disease Modification Effects: https://doi.org/10.3109/
9781439822463.064 - Asenapine versus olanzapine in people with persistent negative symptoms of schizophrenia: https://doi.org/10.1097/jcp.
0b013e31823f880a - Efficacy, Safety, and Tolerability of RBP-7000 Once-Monthly Risperidone for the Treatment of Acute Schizophrenia: An 8-Week, Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study: https://doi.org/10.1097/jcp.
0000000000000479 Palatability and Swallowability of Pimavanserin When Mixed with Selected Food Vehicles: An Exploratory Open-Label Crossover Study: https://doi.org/10.3390/
geriatrics6020061 Immunogenicity and safety of a monovalent Omicron XBB.1.5 SARS-CoV-2 recombinant spike protein vaccine in previously unvaccinated, SARS-CoV-2 seropositive participants: Primary day-28 analysis of a phase 2/3 open-label study: https://doi.org/10.1016/j.
vaccine.2025.127046 And the lie goes on: https://www.discountmags.com/
products/and-the-lie-goes-on- paperback?srsltid= AfmBOoqTHYsRx3TjpO7Ta- wZ1iBbAIuvBctkrTFrXAwfjA7T6YHp d2-d